SINOVAC BIOTECH LTD — Investor Relations & Filings
Filings indexed
567
across all filing types
Latest filing
2025-12-17
Foreign Filer Report
Country
AG
Antigua and Barbuda
Listing
US
SVA
Sinovac Biotech Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. The company's portfolio includes vaccines for influenza and Hepatitis A, among others. Sinovac maintains a strong commitment to innovation, with an active R&D pipeline aimed at developing vaccines for over 20 life-threatening diseases. This research focus is supported by a significant number of patents, scientific publications, and the undertaking of numerous state and local research projects.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K Filing | 2025-12-17 | English | |
| SCHEDULE 13D/A Filing | 2025-12-17 | English | |
| 6-K Filing | 2025-11-20 | English | |
| 6-K Filing | 2025-11-05 | English | |
| SCHEDULE 13D/A Filing | 2025-09-12 | English | |
| 6-K Filing | 2025-08-21 | English |
Browse filings by year
26 years- 2026 15 filings
- 2025 46 filings
- 2024 13 filings
- 2023 23 filings
- 2022 9 filings
- 2021 16 filings
- 2020 23 filings
- 2019 13 filings
- 2018 43 filings
- 2017 21 filings
- 2016 21 filings
- 2015 15 filings
- 2014 13 filings
- 2013 10 filings
- 2012 15 filings
- 2011 23 filings
- 2010 23 filings
- 2009 47 filings
- 2008 39 filings
- 2007 30 filings
- 2006 25 filings
- 2005 34 filings
- 2004 21 filings
- 2003 14 filings
- 2002 12 filings
- 2000 3 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 27225617 | 6-K Filing | 2025-12-17 | English | ||
| 27225529 | SCHEDULE 13D/A Filing | 2025-12-17 | English | ||
| 27225487 | 6-K Filing | 2025-11-20 | English | ||
| 27225503 | 6-K Filing | 2025-11-05 | English | ||
| 27225675 | SCHEDULE 13D/A Filing | 2025-09-12 | English | ||
| 27225405 | 6-K Filing | 2025-08-21 | English | ||
| 11177728 | Major Shareholding Notification 2025 | 2025-07-15 | English | ||
| 11177727 | Major Shareholding Notification 2025 | 2025-07-14 | English | ||
| 11177729 | Major Shareholding Notification 2025 | 2025-07-14 | English | ||
| 11177730 | Major Shareholding Notification 2025 | 2025-07-11 | English | ||
| 11177731 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-07-10 | English | ||
| 11177732 | FORM 6-K | 2025-07-09 | English | ||
| 11177733 | FORM 6-K | 2025-07-09 | English | ||
| 11177745 | FORM 6-K | 2025-07-08 | English | ||
| 11177743 | Major Shareholding Notification 2025 | 2025-07-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SINOVAC BIOTECH LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32608/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32608 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32608 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32608 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32608}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SINOVAC BIOTECH LTD (id: 32608)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.